Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tribioscience is a privately held biotechnology company founded in 2010 by Stanford University scientists. It specializes in providing high-quality reagents—such as antibodies, ELISA kits, qPCR kits—and contract research services to life science laboratories and biotech companies. Its offerings support molecular biology, biochemistry, immunology, infectious diseases research, gene therapy studies, neuroscience investigations, animal experiments, and drug development. The company’s FAST technology paradigm emphasizes flexibility and time savings for researchers. It also offers animal modeling services used by leading academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tribioscience.